Asbestos finally banned nationwide—five years after EPA's stalled partial rule

What it does

This bill bans the manufacture, processing, use, and distribution of commercial asbestos and products containing it, effective immediately upon enactment. It carves out a narrow exception for chlor-alkali facilities (chemical plants using asbestos diaphragms) until 2030, and allows the President to grant one-time, three-year exemptions on national security grounds if no feasible alternative exists. The ban closes a decades-old regulatory gap: asbestos has been partially restricted but never fully prohibited under federal law, despite being a known carcinogen.

Why we flagged it

The bill's operative mechanism is a straightforward prohibition on a known carcinogen, with narrow, transparent exceptions. It is a protective public-health statute, not a regulatory carve-out or subsidy. The naming after Alan Reinstein (a mesothelioma victim and asbestos-ban advocate) is commemorative of the cause, not self-serving.

What the text implies

• The chlor-alkali exception extends until 2030, allowing continued asbestos use in a specific industrial process for five years post-enactment; this may delay full market transition to asbestos-free diaphragms in that sector.
• The national-security exemption grants the President broad discretion to override the ban on a case-by-case basis; the standard ('necessary to protect national security interests' with 'no feasible alternative') is not defined in the bill and may be interpreted expansively.
• The bill does not address legacy asbestos already in buildings and infrastructure; end-use of pre-enactment asbestos-containing products remains lawful, meaning occupants and workers may still encounter asbestos in older structures.
• Impurity exclusions mean asbestos present as an unintended byproduct in other minerals or products is not covered; this may create a regulatory loophole for substances with trace asbestos contamination.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The ban eliminates ongoing exposure to a substance the EPA and WHO classify as a human carcinogen, protecting workers, consumers, and the general public from asbestos-related diseases (mesothelioma, lung cancer, asbestosis). The narrow chlor-alkali exception and national-security waiver do not materially undermine the core protection, as they affect a small industrial sector and require presidential findings of necessity.

Who stands to gain

• asbestos-substitute manufacturers (fiberglass, ceramic fiber, mineral wool producers)
• occupational safety and industrial hygiene service providers

Named in the bill

Toxic Substances Control Act (TSCA), EPA (Environmental Protection Agency), chlor-alkali industry, President of the United States, Committee on Energy and Commerce (House), Committee on Environment and Public Works (Senate), Federal Food, Drug, and Cosmetic Act

Where it stands

3 cosponsors: 3 Democrats.

• Sep 16, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 16, 2025 — Referred to Senate Committee on Environment and Public Works · Congress.gov: “Read twice and referred to the Committee on Environment and Public Works”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 3 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $4,430,000 in lobbying spend. A filing names 104 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Jeff Merkley, the sponsor, reported $514,925 in PAC receipts in the 2026 cycle.

• American Association for Justice — $3,610,000 on 2 filings
• National Mining Association — $820,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.